FDA warns TCT Nutraceuticals over manufacturing-rule failures in OTC hand sanitizer, including no methanol testing.
What happened
FDA reviewed records TCT submitted after FDA's June 16, 2022, and July 8, 2022, requests under section 704(a)(4) of the FD&C Act; the letter does not describe an inspection. FDA found no evidence of identity testing of incoming components or methanol testing of isopropyl alcohol, inadequate finished-product release testing, and an inadequate stability program for its Antibacterial Hand Sanitizer Gel. FDA placed the firm on Import Alert 66-40 on April 15, 2024.
What FDA found
The firm did not test incoming drug components for identity and did not test its isopropyl alcohol active ingredient for methanol.
21 CFR 211.84(d)(1)The firm did not show adequate finished-product release testing for identity and strength of isopropyl alcohol or for impurities, and did not provide test methods.
21 CFR 211.165(a)The firm lacked an adequate stability program and data to support expiry, with results limited to color, clarity, odor, and pH.
21 CFR 211.166(a)
What FDA wants
Respond in writing within 15 working days with what you have done to correct the violations and prevent recurrence. FDA also recommends engaging a qualified consultant before resuming U.S. drug manufacturing.
Who should pay attention
- US brands and retailers selling OTC hand sanitizer made by this contract manufacturer
- US importers and distributors of Malaysian drug products
- quality teams at OTC drug and hand sanitizer manufacturers
This is a summary. Read the original letter on fda.gov.